GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting its Q2 2022 financial results for the period ended June 30, 2022; the company also noted key corporate updates. Highlights of the report included news that the company’s $1 billion processing volume is a 40% increase over Q1 processing volume and more than…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM)”, today announced voting results for each of the matters presented at the company’s annual shareholders’ meeting. There were 71 shareholders represented in person or by proxy, holding 47,019,721 common shares, representing 28.3% of Cybin’s total issued and outstanding common shares…
Flora Growth (NASDAQ: FLGC), a manufacturer and distributor of global cannabis products and brands, is reporting its financial and corporate results for the six months ending June 30, 2022. Highlights of the report include revenue for the company increasing 604% from the same period last year, reaching ~$15 million while gross profit for the company…
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for B2B cross-border shipping in the NAFTA region, today announced that it has filed a Form F-1 with the SEC. “We are incredibly proud of our team and thank them for their…
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today reported its financial results for the quarter ended June 30, 2022, and provided a clinical update of its anti-cancer drug candidates currently in development. “Within…
SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company today announced its entry into a revolving credit facility as well as the launch of a website that allows investors to track the current value of SRAX’s marketable securities portfolio.…
CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain. Recently, the company announced that the FDA had approved an amendment to…
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biopharmaceuticals and other industries. The company today announced approval for its South Easton, Massachusetts, facility to manufacture custom, compliant, hemp-derived CBD nanoemulsions under the processing/manufacturing license of its commercial…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) is a global innovator in drug delivery platforms. The company today issued information to its stakeholders as an aid to conveniently research and understand various non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. “Biotech companies with little to no revenue can still be worth billions,” Raphael…
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting at the upcoming Q3 Investor Summit. The two-day event, which is slated for Aug. 16–17, 2022, is hosted by Investor Summit Group. GreenBox chair Ben Errez will be presenting virtually; his presentation is scheduled for Aug. 17, 2022, at 12:30 p.m. ET.…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has signed a term sheet with its existing lender, Roynat Capital and Export Development Canada (“EDC”) for a $31 million syndicated senior term loan. The proposed facility is a five-year, senior term loan with a 10-year amortization period and interest-only payments for the…
FingerMotion (NASDAQ: FNGR), a mobile data, services, and big data analytics company, announced that it has received $4 million in gross proceeds through a funding agreement with Lind Global Fund II, LP, which is an investment fund managed by New York-based institutional fund manager The Lind Partners. According to the announcement, the funds will provide…
FingerMotion (NASDAQ: FNGR) is positioned for opportunity with a first-mover status in payments processing and consumer data analysis in China. “The company’s big data product, known as Sapientus, has thus far focused on providing predictive services for the reinsurance market as insurance companies seek to establish a system for risk assessment in the country, and…
D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services and the only company building both quantum annealing and gate-based quantum computers, has announced that it will release its financial results for the second quarter ended June 30, 2022. The results will be announced after market close on Tuesday, Aug. 16, 2022, via…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of a positive full written response from the Food and Drug Administration (“FDA”) from its pre-Investigational New Drug (“Pre-IND”) meeting regarding DehydraTECH-CBD for the treatment of hypertension. According to the update, the FDA confirmed agreement with Lexaria’s proposal to…
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has scheduled a conference call and webcast to discuss its earnings for the first half of 2022. The call is slated for Monday, Aug. 15, 2022, at 4:30 p.m. ET. the company plans to release its financial report…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has announced plans to release its 2022 second quarter financial results after market close on Tuesday, Aug. 23, 2022. In addition, EverGen will hold a results and corporate update conference call at 10:00 a.m. ET on Wednesday, Aug. 24, 2022, hosted by Chief…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced preliminary third-quarter results. According to the update, in addition to recent highlights and successes for the company and its EV programs, Mullen is in a strong financial position, with approximately $99 million in cash and cash equivalents on hand as of Aug. 8,…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the appointment of Nicole Lemerond to its board of directors, effective immediately. Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. Throughout her career, she…
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced an at-the-market equity program allowing the company to issue and sell up to $35 million of common shares. According to the announcement, the shares can be sold “from time to time” through the Neo Exchange, the NYSE American LLC…